Browse result page of B3Pdb

The total number entries retrieved from this search are 53, scroll left/right for detailed information.

B3pdbID	PEPTIDE NAME	PEPTIDE SEQUENCE (1-letter)	PEPTIDE SEQUENCE (3-letter)	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATION	PEPTIDE LENGTH	PEPTIDE CONFORMATION	PEPTIDE NATURE	SOURCE/ORIGIN OF PEPTIDE	SMILES	CELL LINE	In vitro CONCENTRATION	In vitro METHOD	In vitro RESULT	ANIMAL MODEL	In vivo CONCENTRATION	In vivo MODE OF DELIVERY	In vivo METHOD	In vivo RESULT	ACTION	TRANSPORT TYPE	SUBCELLULAR LOCALISATION	COMBINATION	PHYSICAL CONDITION	RESPONSE	RESULT	LABEL	PMID
B3pdbIDb3pdb_0071	PEPTIDE NAMEVasoactive Intestina	PEPTIDE SEQUENCE (1-letter)NA	PEPTIDE SEQUENCE (3-letter)NA	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEporcine duodenum, CNS, Cerebrospinal Fluid	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELMongrel dogs, 5 human	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODportacaval shunt procedure	In vivo RESULTNA	ACTIONDoes not cross the BBB. Represents a central nervous system response to the systemic metabolic event	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSENA	RESULTNA	LABELNA	PMID 31806
B3pdbIDb3pdb_0258	PEPTIDE NAMEVasoactive Intestina	PEPTIDE SEQUENCE (1-letter)NA	PEPTIDE SEQUENCE (3-letter)NA	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONNA	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEporcine duodenum, CNS, Cerebrospinal Fluid	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODMongrel dogs, 5 human	In vitro RESULTNA	ANIMAL MODELportacaval shunt procedure	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONDoes not cross the BBB. Represents a central nervous system response to the systemic metabolic event	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSENA	RESULTNA	LABELNA	PMID 31806
B3pdbIDb3pdb_0325	PEPTIDE NAMERVG	PEPTIDE SEQUENCE (1-letter)NA	PEPTIDE SEQUENCE (3-letter)NA	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH29	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSENA	RESULTNA	LABELNA	PMID 27983648
B3pdbIDb3pdb_0425	PEPTIDE NAMEPituitary adenylate	PEPTIDE SEQUENCE (1-letter)HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat	SMILESN[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)O)C(=O)NCC(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectional influx rate constant	RESULT0.00213 mL/(g x min)	LABELDirect iodination	PMID 8246142
B3pdbIDb3pdb_0426	PEPTIDE NAMEPituitary adenylate	PEPTIDE SEQUENCE (1-letter)HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat	SMILESN[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)O)C(=O)NCC(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEInitial distribution volume	RESULT0.0141 ml/g	LABELDirect iodination	PMID 8246142
B3pdbIDb3pdb_0427	PEPTIDE NAMEPituitary adenylate	PEPTIDE SEQUENCE (1-letter)HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat	SMILESN[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)O)C(=O)NCC(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODEfflux study ICU	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEsaturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEhalf life, brain	RESULT11.8 min	LABELDirect iodination	PMID 8246142
B3pdbIDb3pdb_0428	PEPTIDE NAMEPituitary adenylate	PEPTIDE SEQUENCE (1-letter)HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat	SMILESN[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)O)C(=O)NCC(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODEfflux study ICU	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEsaturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBrain elemination rate constant	RESULT0.059 min-1	LABELDirect iodination	PMID 8246142
B3pdbIDb3pdb_0429	PEPTIDE NAMEPituitary adenylate	PEPTIDE SEQUENCE (1-letter)HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat	SMILESN[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)O)C(=O)NCC(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODHPLC	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% injected dose	RESULT76.9 %/g	LABELDirect iodination	PMID 8246142
B3pdbIDb3pdb_0430	PEPTIDE NAMEPituitary adenylate	PEPTIDE SEQUENCE (1-letter)HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat	SMILESN[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)O)C(=O)NCC(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODShake Flask	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSELog P	RESULT-1.42	LABELDirect iodination	PMID 8246142
B3pdbIDb3pdb_0438	PEPTIDE NAMEVasoactive intestina	PEPTIDE SEQUENCE (1-letter)HSDAVFTDNYTRLRKQMAVKKYLNSILN	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat,porcine	SMILESCCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(N)CC1=CN=CN1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(N)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectional influx rate constant	RESULT0.0004 mL/(g x min)	LABELDirect iodination	PMID 12732342
B3pdbIDb3pdb_0439	PEPTIDE NAMEVasoactive intestina	PEPTIDE SEQUENCE (1-letter)HSDAVFTDNYTRLRKQMAVKKYLNSILN	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat,porcine	SMILESCCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(N)CC1=CN=CN1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(N)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEInitial distribution volume	RESULT0.00028 ml/g	LABELDirect iodination	PMID 12732342
B3pdbIDb3pdb_0440	PEPTIDE NAMEVasoactive intestina	PEPTIDE SEQUENCE (1-letter)HSDAVFTDNYTRLRKQMAVKKYLNSILN	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat,porcine	SMILESCCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(N)CC1=CN=CN1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(N)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYin situ brain perfusion	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectional flux rate constant	RESULT0.00216 mL/(g x min)	LABELDirect iodination	PMID 12732342
B3pdbIDb3pdb_0441	PEPTIDE NAMEVasoactive intestina	PEPTIDE SEQUENCE (1-letter)HSDAVFTDNYTRLRKQMAVKKYLNSILN	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat,porcine	SMILESCCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(N)CC1=CN=CN1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(N)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODHPLC	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% injected dose	RESULT86.6 %/g	LABELDirect iodination	PMID 12732342
B3pdbIDb3pdb_0442	PEPTIDE NAMEVasoactive intestina	PEPTIDE SEQUENCE (1-letter)HSDAVFTDNYTRLRKQMAVKKYLNSILN	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat,porcine	SMILESCCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(N)CC1=CN=CN1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(N)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODHPLC	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% injected dose	RESULT69.8 %/g	LABELDirect iodination	PMID 12732342
B3pdbIDb3pdb_0443	PEPTIDE NAMEVasoactive intestina	PEPTIDE SEQUENCE (1-letter)HSDAVFTDNYTRLRKQMAVKKYLNSILN	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat,porcine	SMILESCCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(N)CC1=CN=CN1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(N)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODHPLC	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% injected dose	RESULT72.2 %/g	LABELDirect iodination	PMID 12732342
B3pdbIDb3pdb_0444	PEPTIDE NAMEVasoactive intestina	PEPTIDE SEQUENCE (1-letter)HSDAVFTDNYTRLRKQMAVKKYLNSILN	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,bovine,mouse,rat,porcine	SMILESCCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(N)CC1=CN=CN1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(N)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODShake Flask	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSELog P	RESULT-2.19	LABELDirect iodination	PMID 12732342
B3pdbIDb3pdb_0454	PEPTIDE NAMEOrexin B	PEPTIDE SEQUENCE (1-letter)RPGPPGLQGRLQRLLQANGNHAAGILTM-NH2	PEPTIDE SEQUENCE (3-letter)Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,pig,mouse,rat,porcine	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODHPLC	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEhalf life, serum	RESULT4.4 min	LABELDirect iodination	PMID 10087007
B3pdbIDb3pdb_0455	PEPTIDE NAMEOrexin B	PEPTIDE SEQUENCE (1-letter)RPGPPGLQGRLQRLLQANGNHAAGILTM-NH2	PEPTIDE SEQUENCE (3-letter)Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,pig,mouse,rat,porcine	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODShake Flask	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSELog P	RESULT-1.52	LABELDirect iodination	PMID 10087007
B3pdbIDb3pdb_0500	PEPTIDE NAMEGhrelin	PEPTIDE SEQUENCE (1-letter)GSS(octanoyl)FLSPEHQRVQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEhuman,rat	SMILESCCCCCCCC(=O)OCC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CO)NC(=O)CN	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSENA	RESULTNA	LABELNA	PMID NA
B3pdbIDb3pdb_0511	PEPTIDE NAME[Tyr10] Secretin-27	PEPTIDE SEQUENCE (1-letter)HSDGTFTSEYSRLRDSARLQRLLQGLV	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEGila monster	SMILES[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectional influx rate constant	RESULT0.000954 mL/(g x min)	LABELDirect iodination	PMID 9663454
B3pdbIDb3pdb_0512	PEPTIDE NAME[Tyr10] Secretin-27	PEPTIDE SEQUENCE (1-letter)HSDGTFTSEYSRLRDSARLQRLLQGLV	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEGila monster	SMILES[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEInitial distribution volume	RESULT0.0099 ml/g	LABELDirect iodination	PMID 9663454
B3pdbIDb3pdb_0513	PEPTIDE NAME[Tyr10] Secretin-27	PEPTIDE SEQUENCE (1-letter)HSDGTFTSEYSRLRDSARLQRLLQGLV	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEGila monster	SMILES[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% injected dose	RESULT0.12 %/g	LABELDirect iodination	PMID 9663454
B3pdbIDb3pdb_0514	PEPTIDE NAME[Tyr10] Secretin-27	PEPTIDE SEQUENCE (1-letter)HSDGTFTSEYSRLRDSARLQRLLQGLV	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEGila monster	SMILES[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectional influx rate constant	RESULT0.000899 mL/(g x min)	LABELDirect iodination	PMID 7475950
B3pdbIDb3pdb_0515	PEPTIDE NAME[Tyr10] Secretin-27	PEPTIDE SEQUENCE (1-letter)HSDGTFTSEYSRLRDSARLQRLLQGLV	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEGila monster	SMILES[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEInitial distribution volume	RESULT0.0121 ml/g	LABELDirect iodination	PMID 7475950
B3pdbIDb3pdb_0516	PEPTIDE NAME[Tyr10] Secretin-27	PEPTIDE SEQUENCE (1-letter)HSDGTFTSEYSRLRDSARLQRLLQGLV	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEGila monster	SMILES[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODCapillary depletion	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% capillary	RESULT2%	LABELDirect iodination	PMID 7475950
B3pdbIDb3pdb_0517	PEPTIDE NAME[Tyr10] Secretin-27	PEPTIDE SEQUENCE (1-letter)HSDGTFTSEYSRLRDSARLQRLLQGLV	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEGila monster	SMILES[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODCapillary depletion	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% parenchyma	RESULT98%	LABELDirect iodination	PMID 7475950
B3pdbIDb3pdb_0518	PEPTIDE NAME[Tyr10] Secretin-27	PEPTIDE SEQUENCE (1-letter)HSDGTFTSEYSRLRDSARLQRLLQGLV	PEPTIDE SEQUENCE (3-letter)His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEGila monster	SMILES[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODShake Flask	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSELog P	RESULT-2.76	LABELDirect iodination	PMID 7475950
B3pdbIDb3pdb_0658	PEPTIDE NAMEDes-octanoyl ghrelin	PEPTIDE SEQUENCE (1-letter)GSSFLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYin situ brain perfusion	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectional flux rate constant	RESULT0.000573 mL/(g x min)	LABELDirect iodination	PMID 12130749
B3pdbIDb3pdb_0659	PEPTIDE NAMEDes-octanoyl ghrelin	PEPTIDE SEQUENCE (1-letter)GSSFLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYin situ brain perfusion	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEInitial distribution vaolume	RESULT0.011 ml/g	LABELDirect iodination	PMID 12130749
B3pdbIDb3pdb_0660	PEPTIDE NAMEDes-octanoyl ghrelin	PEPTIDE SEQUENCE (1-letter)GSSFLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODHPLC	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% injected dose	RESULT0.02 %/g	LABELDirect iodination	PMID 12130749
B3pdbIDb3pdb_0661	PEPTIDE NAMEDes-octanoyl ghrelin	PEPTIDE SEQUENCE (1-letter)GSSFLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODShake Flask	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSELog P	RESULT-1.95	LABELDirect iodination	PMID 12130749
B3pdbIDb3pdb_0662	PEPTIDE NAMEDes-octanoyl ghrelin	PEPTIDE SEQUENCE (1-letter)GSSFLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectional influx rate constant	RESULT0.0007944 mL/(g x min)	LABELDirect iodination	PMID 30293893
B3pdbIDb3pdb_0663	PEPTIDE NAMEDes-octanoyl ghrelin	PEPTIDE SEQUENCE (1-letter)GSSFLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEInitial disrobution volume	RESULT0.001775 ml/g	LABELDirect iodination	PMID 30293893
B3pdbIDb3pdb_0815	PEPTIDE NAMEnon-cyclic Amylin	PEPTIDE SEQUENCE (1-letter)KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY	PEPTIDE SEQUENCE (3-letter)Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEsynthetic,honey bee	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODCapillary depletion	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% capillary	RESULT23%	LABELDirect iodination	PMID 24164260
B3pdbIDb3pdb_0957	PEPTIDE NAMEmouse Ghrelin	PEPTIDE SEQUENCE (1-letter)GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODEfflux study ICU	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEsaturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEhalf life, brain	RESULT16.4 min	LABELDirect iodination	PMID 12130749
B3pdbIDb3pdb_0958	PEPTIDE NAMEmouse Ghrelin	PEPTIDE SEQUENCE (1-letter)GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODEfflux study ICU	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEsaturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBrain elemination rate constant	RESULT0.042 min-1	LABELDirect iodination	PMID 12130749
B3pdbIDb3pdb_0959	PEPTIDE NAMEmouse Ghrelin	PEPTIDE SEQUENCE (1-letter)GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODHPLC	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% injected dose	RESULT0.01 %/g	LABELDirect iodination	PMID 12130749
B3pdbIDb3pdb_0960	PEPTIDE NAMEmouse Ghrelin	PEPTIDE SEQUENCE (1-letter)GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODHPLC	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSE% injected dose	RESULT0.005 %/g	LABELDirect iodination	PMID 12130749
B3pdbIDb3pdb_0961	PEPTIDE NAMEmouse Ghrelin	PEPTIDE SEQUENCE (1-letter)GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODShake Flask	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSELog P	RESULT-1.24	LABELDirect iodination	PMID 12130749
B3pdbIDb3pdb_0962	PEPTIDE NAMEmouse Ghrelin	PEPTIDE SEQUENCE (1-letter)GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectional influx rate constant	RESULT0.0001852 mL/(g x min)	LABELDirect iodination	PMID 30293893
B3pdbIDb3pdb_0963	PEPTIDE NAMEmouse Ghrelin	PEPTIDE SEQUENCE (1-letter)GSS(octanoyl)FLSPEHQKAQQRKESKKPPAKLQPR	PEPTIDE SEQUENCE (3-letter)Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg	N-TERMINAL MODIFICATION	C-TERMINAL MODIFICATION	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEInitial disrobution volume	RESULT0.002847 ml/g	LABELDirect iodination	PMID 30293893
B3pdbIDb3pdb_1039	PEPTIDE NAMEβ-Amyloid1-28	PEPTIDE SEQUENCE (1-letter)DAEFRHDSGYQVHHQKLVFFAEDVGSNK	PEPTIDE SEQUENCE (3-letter)Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESN[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)NCC(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C(C)C)C(=O)NCC(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODEfflux study ICU	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEhalf life, brain	RESULT20.6 min	LABELDirect iodination	PMID 1786560
B3pdbIDb3pdb_1040	PEPTIDE NAMEβ-Amyloid1-28	PEPTIDE SEQUENCE (1-letter)DAEFRHDSGYQVHHQKLVFFAEDVGSNK	PEPTIDE SEQUENCE (3-letter)Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESN[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)NCC(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C(C)C)C(=O)NCC(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODEfflux study ICU	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEBrain elemination rate constant	RESULT0.015 min-1	LABELDirect iodination	PMID 1786560
B3pdbIDb3pdb_1041	PEPTIDE NAMEβ-Amyloid1-28	PEPTIDE SEQUENCE (1-letter)DAEFRHDSGYQVHHQKLVFFAEDVGSNK	PEPTIDE SEQUENCE (3-letter)Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESN[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)NCC(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C(C)C)C(=O)NCC(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODShake Flask	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSELog P	RESULT-1.53	LABELDirect iodination	PMID 1786560
B3pdbIDb3pdb_1042	PEPTIDE NAMEβ-Amyloid1-28	PEPTIDE SEQUENCE (1-letter)DAEFRHDSGYQVHHQKLVFFAEDVGSNK	PEPTIDE SEQUENCE (3-letter)Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODCapillary deplition in situ b p	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPENA	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectonal influx rate constant	RESULT0.00098 mL/(g x min)	LABELDirect iodination	PMID 8280117
B3pdbIDb3pdb_1043	PEPTIDE NAMEβ-Amyloid1-28	PEPTIDE SEQUENCE (1-letter)DAEFRHDSGYQVHHQKLVFFAEDVGSNK	PEPTIDE SEQUENCE (3-letter)Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESN[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)NCC(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C(C)C)C(=O)NCC(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectional influx rate constant	RESULT0.000386 mL/(g x min)	LABELDirect iodination	PMID 1786560
B3pdbIDb3pdb_1044	PEPTIDE NAMEβ-Amyloid1-28	PEPTIDE SEQUENCE (1-letter)DAEFRHDSGYQVHHQKLVFFAEDVGSNK	PEPTIDE SEQUENCE (3-letter)Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH28	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDENA	SMILESN[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)NCC(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(C(C)C)C(=O)NCC(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)O	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEnon saturable	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEInitial disrobution volume	RESULT0.0159 ml/g	LABELDirect iodination	PMID 1786560
B3pdbIDb3pdb_1093	PEPTIDE NAMESNX-231	PEPTIDE SEQUENCE (1-letter)CKGKGA-Hyp-CRKTMYDCCSGSCGRRGKC	PEPTIDE SEQUENCE (3-letter)Cys-Lys-Gly-Lys-Gly-Ala-Hyp-Cys-Arg-Lys-Thr-Met-Tyr-Asp-Cys-Cys-Ser-Gly-Ser-Cys-Gly-Arg-Arg-Gly-Lys-Cys	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONCys1-Cys16; Cys8-Cys20; Cys15-Cys26	PEPTIDE LENGTH26	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODBMEC	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEPermeability coefficient	RESULT0.00001317 cm/s	LABELNA	PMID 10822104
B3pdbIDb3pdb_1094	PEPTIDE NAMESNX-185	PEPTIDE SEQUENCE (1-letter)CLS-Hyp-GSSCS-Hyp-TSYNCCRSCN-Hyp-YSRKCR	PEPTIDE SEQUENCE (3-letter)Cys-Leu-Ser-Hyp-Gly-Ser-Ser-Cys-Ser-Hyp-Thr-Ser-Tyr-Asn-Cys-Cys-Arg-Ser-Cys-Asn-Hyp-Tyr-Ser-Arg-Lys-Cys-Arg	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONCys1-Cys16; Cys8-Cys20; Cys15-Cys26	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODBMEC	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYNA	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEPermeability coefficient	RESULT0.0000145 cm/s	LABELNA	PMID 10822104
B3pdbIDb3pdb_1186	PEPTIDE NAMEAH-D	PEPTIDE SEQUENCE (1-letter)SGSWLRDVWDWICTVLTDFKTWLQSKL	PEPTIDE SEQUENCE (3-letter)Ser-Gly-Ser-Trp-Leu-Arg-Asp-Val-Trp-Asp-Trp-Ile-Cys-Thr-Val-Leu-Thr-Asp-Phe-Lys-Thr-Trp-Leu-Gln-Ser-Lys-Leu	N-TERMINAL MODIFICATIONNA	C-TERMINAL MODIFICATION NA	CHEMICAL MODIFICATIONNA	PEPTIDE LENGTH27	PEPTIDE CONFORMATIONLinear	PEPTIDE NATURENA	SOURCE/ORIGIN OF PEPTIDEChemically synthesized	SMILESNA	CELL LINENA	In vitro CONCENTRATIONNA	In vitro METHODNA	In vitro RESULTNA	ANIMAL MODELNA	In vivo CONCENTRATIONNA	In vivo MODE OF DELIVERYIntravenous	In vivo METHODNA	In vivo RESULTNA	ACTIONNA	TRANSPORT TYPEPermeability	SUBCELLULAR LOCALISATIONNA	COMBINATIONNA	PHYSICAL CONDITIONNA	RESPONSEUnidirectional influx rate constant	RESULT0.0003853 mL/(g x min)	LABELNA	PMID 30349030